Nicholas Grund
2018
Compensation breakdown
| Non-Equity Incentive Plan | $306,100 |
|---|---|
| Option Awards | $257,244 |
| Salary | $492,559 |
| Stock Awards | $544,320 |
| Other | $11,000 |
| Total | $1,611,223 |
Grund received $544.3K in stock awards, accounting for 34% of the total pay in 2018.
Grund also received $306.1K in non-equity incentive plan, $257.2K in option awards, $492.6K in salary and $11K in other compensation.
Rankings
In 2018, Nicholas Grund's compensation ranked 6,826th out of 14,244 executives tracked by ExecPay. In other words, Grund earned more than 52.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,826 out of 14,244 | 52nd |
Division Manufacturing | 2,613 out of 5,765 | 55th |
Major group Chemicals And Allied Products | 984 out of 2,128 | 54th |
Industry group Drugs | 826 out of 1,817 | 55th |
Industry Pharmaceutical Preparations | 644 out of 1,391 | 54th |
Pay ratio
| Nicholas Grund's Pay | $1,611,223 |
|---|---|
| Median Employee's Pay | $195,142 |
| Pay Ratio | 8to 1 |
In 2018, the annual total compensation of Nicholas Grund was $1,611,223.
The annual total compensation of the median employee at AMAG Pharmaceuticals was $195,142.
The ratio of Nicholas Grund's pay to the pay of median employee was therefore 8 to one.
Grund's colleagues
We found five more compensation records of executives who worked with Nicholas Grund at AMAG Pharmaceuticals in 2018.
2018
William Heiden
AMAG Pharmaceuticals
Chief Executive Officer
2018
J Butcher
AMAG Pharmaceuticals
Chief Business Officer and Executive Vice President
2018
Julie Krop
AMAG Pharmaceuticals
Chief Medical Officer
2018
Edward Myles
AMAG Pharmaceuticals
Chief Financial Officer
2018
Joseph Vittiglio
AMAG Pharmaceuticals